Joel Unowsky is a notable inventor based in Livingston, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in enhancing the absorption of antibiotics. With a total of 4 patents to his name, Unowsky's work has the potential to improve the efficacy of antibiotic treatments.

Latest Patents

Unowsky's latest patents focus on the absorption enhancement of antibiotics. One of his innovations involves a two-component absorption enhancing system that significantly improves the oral absorption of antibiotics. This system includes Laureth-12 and salts of capric acid and caprylic acids, along with Miglyol-812 for optimum absorption. Another patent addresses the absorption of antibiotics administered through oral and rectal routes. This invention utilizes an ether of a C.sub.6 to C.sub.18 alcohol and a polyoxyethylene glycol, combined with various glyceride esters and carboxylic acids. These compositions can be conveniently administered in various forms, including tablets, capsules, beadlets, and suppositories.

Career Highlights

Joel Unowsky is currently associated with Hoffmann-La Roche Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new methods for enhancing drug absorption, which is crucial for effective treatment outcomes.

Collaborations

Unowsky has collaborated with notable colleagues such as Navnit Hargovindas Shah and Charanjit R Behl. Their combined expertise has contributed to the advancement of pharmaceutical innovations.

Conclusion

Joel Unowsky's contributions to antibiotic absorption enhancement represent a significant advancement in pharmaceutical science. His innovative patents and collaborations highlight his commitment to improving healthcare outcomes through effective drug delivery systems.